RVSN Q3 2023 Earnings EPS Exceeds Estimates Despite Absence of Revenue DRMA Q1 2026 Earnings NarrowerthanExpected Loss Marks Progress for ClinicalStage Biotech HBANP Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Banking Environment STZ Q1 2026 Earnings EPS Surprise Beats Estimates Despite Flat Revenue Disclosure MSN Q1 2024 Earnings Narrowing Losses Amid Limited Revenue Disclosure Stock Surges 2026 IPHA Q1 2026 Earnings EPS Misses Estimates Significantly Yet Stock Rises